Pain. Pain in limb
Conditions
Interventions
Intervention 1: 15 mg of bupivacaine 0.5% (3 cc) with 0.5 mg of midazolam. Intervention 2: 15 mg of bupivacaine 0.5% (3 cc) with fentanyl 25 microgram (µg). Intervention 3: 15 milligram (mg) of bupiva
Placebo
15 mg of bupivacaine 0.5% (3 cc) with 0.5 mg of midazolam
15 mg of bupivacaine 0.5% (3 cc) with fentanyl 25 microgram (µg)
15 milligram (mg) of bupivacaine 0.5% (equivalent to 3 cc) with 0.5 milliliter (ml) of normal saline
Sponsors
Golestan University of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: people aged 18-65 years that categorized into class 1 and 2 based on America Society of Anesthesiologists (ASA); Exclusion criteria : rejection of patients with substance abuse, patients with symptoms of neuropathy, and lack of appropriate sensory level after performing the spinal anesthesia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of analgesia. Timepoint: After intervention. Method of measurement: Duration of analgesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic Change. Timepoint: Before Intervention, 30 ,60 and 90 minutes after intervention. Method of measurement: Sphygmomanometer, Pols oximeter.;Chills. Timepoint: After intervention. Method of measurement: Observation.;Nausea. Timepoint: After intervention. Method of measurement: Observation.;Vomiting. Timepoint: After intervention. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHomeira Khodam
Golestan University of Medical Science
Outcome results
None listed